Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Feb 13, 2018

30597_dirs_2018-02-13_c1e3c293-3c9e-4fbd-8dc6-21832031a7c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-12-31

Reporting Person: Elliott Jeffrey Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-31 Common Stock A 679 $13.26 Acquired 14694 Direct

Footnotes

F1: Represents shares purchased through Employee Stock Purchase Plan.